Specifically, CoQ10 treatment resulted in downregulated IL1β expressions in infarct myocardium and CCR2+ macrophages at the early inflammatory stage, as well as reduced IL1β expression in cardiac macrophages at the remodeling stage post-MI. This evidence concerns the gene CCR2 and myocardial infarction.